31-45 of 234
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiersASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiersSafety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiersNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
Closing Care Gaps and Addressing Unmet Needs in SMA
NeuroFrontiersClosing Care Gaps and Addressing Unmet Needs in SMA
Examining Care Collaborations for Patients with SMA
NeuroFrontiersExamining Care Collaborations for Patients with SMA
- advertisement
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
On the Frontlines of MigraineThe Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
On the Frontlines of PsoriasisGenetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiersQuantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiersCardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Balancing Benefits and Risks in Emerging Sickle Cell Therapies
Project Oncology®Balancing Benefits and Risks in Emerging Sickle Cell Therapies
- advertisement
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Clinician's RoundtableTargeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiersGene Therapy Safety in DMD: How to Identify Common Immune Reactions
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiersOptimizing DMD Care Through Multidisciplinary Collaboration
